Clexio Biosciences is a CNS-first clinical stage company. We are dedicated to developing novel drugs and technologies for patients suffering from neurological and psychiatric conditions.
for people
Before we create, we listen
At Clexio, we strive to be genuinely patient-centered and to set new standards of therapeutic-experience-driven development.
by people
Our team
We believe in the power of collaboration – both internally and externally. Our people are the key ingredients in our success.